Immuneering
Price & Volume
Stats
See more52W Range | $1-$8.07 |
Market Cap | $50.7M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $455 |
Revenue Growth (YoY) | -99.8% |
Gross Profit (12 Mos) | $158,830 |
Diluted EPS | -$1.97 |
News
See moreYahoo Finance • last year
Immuneering to Present at the 35th Annual Piper Sandler Healthcare Conference
Yahoo Finance • last year
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Immuneering Corporation (NASDAQ: IMRX) and Encourages Investors to Contact the Firm
Yahoo Finance • last year
Immuneering Reports Third Quarter 2023 Financial Results and Provides Business Updates
About
CEO | Dr. Benjamin J. Zeskind M.B.A., Ph.D. |
Address | 245 Main Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 66 |
